SFL’s CEO, Shayesteh Fürst-Ladani, attended the 2021 edition of the Swiss-Korean Life Science Symposium on 03 November 2021. The Symposium hosts experts from Switzerland and Korea to exchange relevant industry knowledge and encourage collaboration in all areas of healthcare. This year the Symposium focused on the post-pandemic era’s impact through three parallel sessions: Assistive Technologies for Ageing Societies, Cell and Gene Therapy, and Digital Health.
During the Cell and Gene Therapy session, Shayesteh presented the Swiss and EU perspective on the development and regulatory challenges in the European cell and gene therapy ecosystem. After this presentation she participated in an expert panel discussion on the topics of the session.
Contact us to arrange a meeting to discuss how SFL can support your company’s product development.